METHOD FOR TREATING AND PREVENTING DISEASES CAUSED BY INCREASING CONTENTS OF A FACTOR INDUCING TUMOR CELL NECROSIS

medicine. SUBSTANCE: method involves administering tumor necrosis factor inhibitor at a dose of 0.1 to 200 mg/kg of body mass. The tumor necrosis factor is a protein selected from tumor necrosis factor inhibitor 30 kDa, tumor necrosis factor inhibitor 40 kDa, tumor necrosis factor Δ 53 inhibitor 40...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TADAKHIKO KOKHNO, ROBERT K. TOMPSON, DEBORA RASSELL, DEHVID F. KARMAJKL, KRISTOFER G. SMIT
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	medicine. SUBSTANCE: method involves administering tumor necrosis factor inhibitor at a dose of 0.1 to 200 mg/kg of body mass. The tumor necrosis factor is a protein selected from tumor necrosis factor inhibitor 30 kDa, tumor necrosis factor inhibitor 40 kDa, tumor necrosis factor Δ 53 inhibitor 40 kDa or, tumor necrosis factor Δ 51 inhibitor 40 kDa. EFFECT: enhanced effectiveness in treating lung fibrosis, osteoarthritis, ankylosing spondylitis, lupus erythematosus, gonococcus-induced arthritis, Reiter disease arthritis and gout. 13 cl, 17 dwg, 4 tbl